These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27095790)

  • 21. Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.
    Libois A; Florence E; Derdelinckx I; Yombi JC; Henrard S; Uurlings F; Vandecasteele S; Allard SD; Demeester R; Van Wanzeele F; Ausselet N; De Wit S
    Acta Clin Belg; 2018 Aug; 73(4):275-280. PubMed ID: 29429390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999-2012.
    Lunding S; Katzenstein TL; Kronborg G; Storgaard M; Pedersen C; Mørn B; Lindberg JÅ; Kronborg TM; Jensen J
    Infect Dis (Lond); 2016; 48(3):195-200. PubMed ID: 26529586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infections.
    Pereira IO; Pascom A; Mosimann G; Barros Perini F; Coelho RA; Rick F; Benzaken A; Avelino-Silva VI
    HIV Med; 2020 Apr; 21(4):240-245. PubMed ID: 31730296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to post-exposure prophylaxis following sexual exposure for men who have sex with men in an Irish healthcare setting.
    McFaul K; Rowley D; O'Reilly A; Clarke S
    Int J STD AIDS; 2015 Jul; 26(8):521-5. PubMed ID: 25139004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will I? Won't I? Why do men who have sex with men present for post-exposure prophylaxis for sexual exposures?
    Sayer C; Fisher M; Nixon E; Nambiar K; Richardson D; Perry N; Llewellyn C
    Sex Transm Infect; 2009 Jun; 85(3):206-11. PubMed ID: 19074929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Post-exposure HIV prevention: eligibility of patients recently infected by sexual exposure].
    Sudre P; San Millán Ruiz D; Fagard C; Perrin L; Hirschel BJ
    Schweiz Med Wochenschr; 1999 Feb; 129(8):314-8. PubMed ID: 10189668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
    HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEPSE and coke: should we be increasing awareness of HIV post-exposure prophylaxis for consensual risk exposures?
    Zimmer R
    HIV Med; 2014 Apr; 15(4):255-6. PubMed ID: 24581325
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia.
    Guinot D; Ho MT; Poynten IM; McAllister J; Pierce A; Pell C; Grulich AE
    HIV Med; 2009 Apr; 10(4):199-208. PubMed ID: 19207598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can emergency departments fulfil BASHH recommendations for 24-hour access to HIV postexposure prophylaxis following sexual exposure?
    Arkell P; Abouyannis M; Manavi K
    Int J STD AIDS; 2012 Jan; 23(1):75-6. PubMed ID: 22362701
    [No Abstract]   [Full Text] [Related]  

  • 34. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growing HIV pandemic.
    Miles K
    Community Pract; 2005 Aug; 78(8):292-4. PubMed ID: 16114721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current perspectives in HIV post-exposure prophylaxis.
    Sultan B; Benn P; Waters L
    HIV AIDS (Auckl); 2014; 6():147-58. PubMed ID: 25368534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can the promotion of post-exposure prophylaxis following sexual exposure to HIV (PEPSE) cause harm?
    Richens J; Edwards SG; Sadiq ST
    Sex Transm Infect; 2005 Jun; 81(3):190-1; discussion 191-2. PubMed ID: 15923282
    [No Abstract]   [Full Text] [Related]  

  • 39. Is HIV post-exposure prophylaxis required following occupational exposure to a source patient who is virologically suppressed on antiretroviral therapy?
    Webster DP
    HIV Med; 2015 Feb; 16(2):73-5. PubMed ID: 25597403
    [No Abstract]   [Full Text] [Related]  

  • 40. Postexposure prophylaxis after sexual exposure to HIV.
    Roland ME
    Curr Opin Infect Dis; 2007 Feb; 20(1):39-46. PubMed ID: 17197880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.